Clinical trial

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

NCT01955161

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Idalopirdine Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-10-01

PhasePHASE3

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

PlaceboDRUG

IdalopirdineDRUG

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

Otsuka Pharmaceutical Co., Ltd.collaborator

Mapped research locations

SofiaBulgaria5 Buenos AiresArgentina4 New YorkNew York, United States3 PragueCzechia3 SantiagoChile3 ParisFrance2 BrusselsBelgium2 KyivUkraine2 Cape TownSouth Africa2 Toms RiverNew Jersey, United States2 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01955161 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.